Vitaku E.,Smith D.T.,Njardarson and J.T. .2014 .Analysis of the structural diversity, substitution patterns, and frequency of nitrogen heterocycles among US FDA approved pharmaceuticals: miniperspective. J. Med, 57(10257) : .
Frieri M.,Kumar K.,Boutin A. .2017 .and. , 10(369) : .
Kumari L.,Mazumder A.,Pandey D.,Yar M.S.,Kumar R.,Mazumder R.,Sarafroz M.,Ahsan M.J.,Kumar V.,Gupta S. .2019 .Synthesis and biological potentials of quinoline analogues: A review of literatüre. Mini-Rev. Org. Chem, 16(653) : .
Matada B.S.,Pattanashettar R.,Yernale N.G. .2021 .A comprehensive review on the biological interest of quinoline and its derivatives. Bioorg. & Med, 32(115973) : .
Salahuddin S.,Mazumder A. .2017 .Benzimidazoles: A biologically active compounds. Arabian J. Chem, 10(S157) : .
Diaconu D.,Amăriucăi-Mantu D.,Mangalagiu V.,Antoci V.,G. V. .2021 .Zbancioc, and II. Mangalagiu, Ultrasound assisted synthesis of hybrid quinoline-imidazole derivatives: a green synthetic approach, RSC adv. , 11(38297) : .
Diaconu D.,Mangalagiu V.,AmariucaiMantu D.,Antoci V.,Giuroiu C.L. .2020 .Hybrid quinoline-sulfonamide complexes (M2+) derivatives with antimicrobial activity, Molecules. , 25(2946) : .
Ebenezer O.,Oyetunde-Joshua F.,Omotoso O.D.,Shapi M. .2023 .Benzimidazole and its derivatives: Recent Advances (. Res. Chem, 100925 : .
Kabir E.,Uzzaman M. .2022 .A review on biological and medicinal impact of heterocyclic compounds. Res. Chem, 100606 : .
Tahlan S.,Kumar S.,Narasimhan B. .2019 .Antimicrobial potential of 1H-benzo [d] imidazole scaffold: a review, BMC Chem. , 13(1) : .
Lopes F.V.,Stroppa P. H. F.,Marinho J.A.,Soares R.R.,Goliatt P.V.Z.C.,Abramo C. .2021 .Synthesis, docking, cytotoxicity analysis and in vivo antimalarial activity. ChemBiol, 350(109688) : 3.
El‐Sebaey .2020 .. Recent Advances in 1, 5(11654) : 4.
R.J. Brüggemann R.,Verheggen M.,Stanzani P.E.,Verweij N.M.,Blijlevens R.E.,Lewis R.E. .2022 .Management of drug-drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugs, Lancet. , 9(e58) : .
Bozorov K.,Zhao J.,Aisa H.A. .2019 .- Triazole-containing hybrids as leads in medicinal chemistry: A recent overview. Bioorg. Med, 27(3511) : .
Warrilow A.G.S.,Hull C.M.,Parker J.E.,Garvey E. P.,Hoekstra W. J.,Moore W. R.,Schotzinger R. J.,Kelly D. E.,Kelly S. L. .2014 .The clinical candidate VT-1161 is a highly potent inhibitor of Candida albicans CYP51 but fails to bind the human enzyme, Antimicrob. , 58(7121) : .
M. Keenan J.H.,Chaplin J.H. .2015 .A new era for Chagas disease drug discovery?. Prog. Med, 54(185) : .
Ö N.,Acar Çevik U.,Sağlık B.N.,Levent S.,Korkut B.,Özkay Y.,Kaplancıklı Z.A.,Koparal A.S. .2017 .Synthesis, molecular docking studies, and antifungal activity evaluation of new benzimidazole-triazoles as potential lanosterol 14α-demethylase inhibitors. J. Chem, : .
H. Karaca Gençer U.,Acar Çevik S.,Levent B.N.,Sağlık B.,Korkut Y.,Özkay S.,Ilgın Y.,Öztürk Y. .2017 .-triazole hybrid compounds: Synthesis, anticandidal activity and cytotoxicity evaluation, Molecules. , 22(507) : .
Evren A.E.,Bostancı H.E.,Gül Y.,Özkay Z.A.,Kaplancıklı Z.A. .2023 .-triazole derivatives as potential antifungal agents targeting 14α-demethylase, ACS omega. Synthesis of benzimidazole1,2, 8(4369) : .
Çevik I. Celik,Işık A.,Pillai R.R.,Tallei T.E.,Yadav R.,Özkay Y.,Kaplancıklı Z.A. .2022 .Synthesis, molecular modeling, quantum calculations and ADME estimation studies of benzimidazole-oxadiazole derivatives as potent antifungal agents. J. Mol. Struct, 1252(132095) : .
Dallakyan S.,Olson A.J. .2015 .Methods Protoc. , 243 : .
Daina A.,Michielin O.,Zoete V. .2017 .SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep, 7(42717) : .
D.R. Koes C.J.,Camacho C.J. .2012 .ZINCPharmer: pharmacophore search of the ZINC database, Nucleic acids res. , 40(W409) : .
Hargrove L.,Friggeri Z.,Wawrzak A.,Oi W.J.,Hoekstra R.J.,Schotzinger J.D.,York F.P.,Guengerich G.I. Lepesheva .2017 .Structural analyses of Candida albicans sterol 14α- demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis. J. Biol. Chem, 292(6728) : .